Nova Leap Health Corp.
NVLPF
$0.1803
-$0.0271-13.07%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.71% | 2.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.71% | 2.80% | |||
| Cost of Revenue | 7.86% | 0.98% | |||
| Gross Profit | 7.47% | 5.77% | |||
| SG&A Expenses | 13.15% | 6.02% | |||
| Depreciation & Amortization | 32.61% | 1.50% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.27% | 2.68% | |||
| Operating Income | -66.00% | 6.30% | |||
| Income Before Tax | -107.08% | 830.47% | |||
| Income Tax Expenses | -99.08% | 225.21% | |||
| Earnings from Continuing Operations | -108.83% | 526.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -108.83% | 526.31% | |||
| EBIT | -66.00% | 6.30% | |||
| EBITDA | -6.47% | -17.95% | |||
| EPS Basic | -108.74% | 529.17% | |||
| Normalized Basic EPS | -102.38% | 4,300.00% | |||
| EPS Diluted | -110.00% | 516.67% | |||
| Normalized Diluted EPS | -102.38% | 4,300.00% | |||
| Average Basic Shares Outstanding | 1.11% | 0.17% | |||
| Average Diluted Shares Outstanding | 1.11% | -1.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||